BioPurification/ BioProcessing

Importance of Biopurification

Crucial !

  • The Cost Driver: Purification is essential to ensure the safety and efficacy of pharmaceuticals, biologics, chemicals, and food products. However, it is also a massive financial bottleneck, often constituting more than 70% of total manufacturing costs for products like monoclonal antibodies (MAbs).

  • Market Pressures: While biotech and pharmaceutical profit margins can be high, process economics are paramount—especially for biosimilars and generic pharmaceutical manufacturing, where market dynamics demand ultra-efficient production methods.

Critical Industries and Vast Markets Biopurification serves the pharmaceutical and biotech sectors which are pillars of the international economies with large sophisticated customer base.

Purification of organism-made (biotech) protein-drugs is complex and costly. Although successful pharmaceuticals enjoy high profit margins, process economics remain significant.

This applies specially to manufacturing of generic and bio-similar pharmaceuticals, as market dynamics will force economical and effective methods of production.

While polymeric gel beads remain widely used for high-capacity purification, their reliance on standard packed-bed designs introduces severe operational bottlenecks:

Limitations of Conventional Purification (Gel Columns & Beads)

Unfavorable flow characteristics

  • Inefficient Diffusive Flow: The vast majority of a gel bead's binding capacity relies on slow internal diffusion rather than rapid convective flow. Increasing operational pressure speeds up fluid passage around the particles, but fails to accelerate mass transfer inside them.

  • High-Pressure Vulnerabilities: Large-scale columns (often hundreds of gallons) require thousands of pounds per square inch (PSI) of pressure. This drives up capital costs and technical complexity, risks deforming or collapsing the beads, and can cause catastrophic loss of potency in delicate protein therapeutics.

  • Inhomogeneous Binding: Because molecules must slowly diffuse inward to access active binding sites, binding and release profiles are uneven, limiting throughput and consistency.

  • Intensive Labor & Setup: Column packing and support require specialized, highly skilled labor and substantial setup time, introducing bottlenecks into production workflows.

ILS introduced SmartGel, a breakthrough purification matrix engineered to create an efficient molecular "net" for the precise capture and release of target molecules in complex fluids.

By configuring SmartGel matrices within devices designed for substantially convective flow, ILS overcomes the limitations of traditional diffusion. Combined with exceptionally high binding capacity, fast convective flow allows SmartGel devices to rapidly extract and concentrate target molecules—even from extremely dilute or high-volume solutions.

Solution: ILS SmartGel©

SmartGel Columns

ILS has produced a variety of SmartGel purification columns to address extraction of a variety of classes of molecular species.

R&D Scale SmartGel Columns

ILS has developed and tested columns with capacity from mg to gram capacity, and with functionalities including ion exchangers, nucleic acids extraction, affinity (antibody/antigen) binding, heavy metal chelation, and hydrophilic filters have been prepared and utilized.

The columns' performance has demonstrated remarkable bind and release characteristics of compounds including immunoglobulins and other proteins, DNA/RNA, and multivalent ions. SmartGel columns were shown to exhibit outstanding performance compared to on-market competitors.

Performance

The columns' performance has demonstrated remarkable bind and release characteristics of compounds including immunoglobulins and other proteins, DNA/RNA, and multivalent ions. SmartGel were shown to exhibit outstanding performance compared to on-market competitors.

Large Scale SmartGel Columns

Extraordinary Advantages: Major Improvements for Bioprocessing and Biopharmaceutical Manufacturing

1. High-Performance Bioprocessing & Drug Manufacturing Columns

Due to predominantly convective flow characteristics of the SmartGel structure. ILS large-scale columns solve the critical scale-up challenges of modern biopharmaceuticals. It delivers impressive binding capacity and significantly higher fluid flow rates at ultra-low operating pressures. This enables the safe purification of delicate protein drugs and biologics without shear-induced degradation.

2. Seamless R&D-to-Production Scalability

Manufactured via a consistent core process, SmartGel scales seamlessly from milligram quantities (R&D) to kilogram industrial scales. This direct scalability substantially reduces process development time and cycle duration.

3. Plug-and-Play Operational Efficiency

Unlike messy, labor-intensive bulk gel particles that require extensive column packing and validation, SmartGel is delivered in ready-to-use or customizable plug-in formats, driving massive time and labor savings.

4. Lower Cost & Smaller Footprint

Provides lower capital expenditure, reduced consumable/labor costs, and a significantly smaller physical footprint while maintaining a strong margin advantage over conventional poured gel beads.

SmartGel Column Applications

SmartGel columns are provided in capacities from milligrams to large scales up to kilograms of target molecules, with starting volumes up to thousands of liters . This facilitates migration and transferability from R&D to larger scale production, with substantial reduction cost and in process development time.

ILS has developed a versatile portfolio of SmartGel purification columns tailored for diverse molecular classes and extraction workflows:

  • Extracts Diverse Target Classes: Ion exchange, nucleic acid extraction (DNA/RNA), affinity (antibody/antigen) binding, heavy metal chelation, and advanced hydrophilic filters.

  • Proven Performance: Demonstrated remarkable bind-and-release efficiency for immunoglobulins, complex proteins, DNA/RNA, and multivalent ions, outperforming leading on-market competitors.

  • Environmental & Industrial Impact: Beyond biopharma, SmartGel offers an exciting and powerful solutions for targeted extraction and recycling of heavy metals and other environmental hazards.

  • low operating pressures

    Due to predominantly convective flow characteristics of the SmartGel structure. ILS large-scale columns solve the critical scale-up challenges of modern biopharmaceuticals. It delivers impressive binding capacity and significantly higher fluid flow rates at ultra-low operating pressures. This enables the safe purification of delicate protein drugs and biologics without shear-induced degradation.